aTyr Pharma Inc (LIFE)
1.57
-0.02
(-1.57%)
USD |
NASDAQ |
Apr 26, 16:00
1.60
+0.03
(+1.91%)
After-Hours: 20:00
aTyr Pharma Total Liabilities (Quarterly): 30.18M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 30.18M |
| September 30, 2023 | 26.87M |
| June 30, 2023 | 26.70M |
| March 31, 2023 | 27.14M |
| December 31, 2022 | 24.50M |
| September 30, 2022 | 19.05M |
| June 30, 2022 | 9.558M |
| March 31, 2022 | 6.402M |
| December 31, 2021 | 6.411M |
| September 30, 2021 | 6.477M |
| June 30, 2021 | 8.19M |
| March 31, 2021 | 5.596M |
| December 31, 2020 | 7.242M |
| September 30, 2020 | 9.638M |
| June 30, 2020 | 11.62M |
| March 31, 2020 | 12.48M |
| December 31, 2019 | 15.16M |
| September 30, 2019 | 17.01M |
| June 30, 2019 | 18.54M |
| Date | Value |
|---|---|
| March 31, 2019 | 20.43M |
| December 31, 2018 | 19.10M |
| September 30, 2018 | 20.79M |
| June 30, 2018 | 22.93M |
| March 31, 2018 | 23.97M |
| December 31, 2017 | 25.11M |
| September 30, 2017 | 22.20M |
| June 30, 2017 | 21.44M |
| March 31, 2017 | 15.03M |
| December 31, 2016 | 17.72M |
| September 30, 2016 | 11.94M |
| June 30, 2016 | 13.92M |
| March 31, 2016 | 14.69M |
| December 31, 2015 | 14.62M |
| September 30, 2015 | 12.21M |
| June 30, 2015 | 13.74M |
| March 31, 2015 | 157.91M |
| December 31, 2014 | 111.65M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
5.596M
Minimum
Mar 2021
30.18M
Maximum
Dec 2023
15.20M
Average
12.48M
Median
Mar 2020
Total Liabilities (Quarterly) Benchmarks
| Vaxart Inc | 34.02M |
| Allogene Therapeutics Inc | 130.60M |
| AIM ImmunoTech Inc | 9.147M |
| Protalix BioTherapeutics Inc | 50.86M |
| Armata Pharmaceuticals Inc | 130.43M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 120.65M |
| Shareholders Equity (Quarterly) | 90.66M |